The Latest Breaking News from John Eng

What a desert lizard teaches us about patents and the GLP-1 revolution

The GLP-1 story shows how patents can reward discovery and push rivals to develop better drugs.

Fortune · Oct 10

2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stage

Predictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Carl June is mentioned for his role in developing CAR-T cell therapy for cancer treatment. Researchers Emmanuel Mignot and Masashi Yanagisawa are noted for their work on orexin related to sleep…

The Economic Times · Sep 30

How the Gila Monster's Saliva Became a Diabetes Drug Now Used by Millions Worldwide

The lizard that never eats, yet never crashesThe Gila Monster can go up to a year without a meal. That is not hyperbole, it is a documented biological fact about one of only two venomous lizard species native to North America. During those long stretches of fasting, its blood glucose…

Times Life · Aug 21